Cure8 research brief
The gut microbiome differed more in pediatric Crohn’s disease and acute pancreatitis than in IBS or healthy kids, suggesting microbial changes are stronger in organic inflammatory disease and could be targets for future treatments or biomarkers.
Pediatric gastroenterologists, microbiome researchers, clinicians managing children with Crohn’s disease or acute pancreatitis, and families interested in microbiome-focused research.
This report used shotgun metagenomic sequencing on stool from 120 children and teens (AP n=30, CD n=29, IBS n=27, healthy controls n=34) and analyzed taxonomic and functional profiles. Measures of alpha diversity (Shannon) were lower in AP and CD versus IBS and healthy controls, and community composition clustered by diagnosis.
Specific species (for example Escherichia coli, Ruminococcus gnavus, Staphylococcus aureus) were enriched in the organic disease groups compared with controls. A machine-learning model distinguished CD and AP samples from others with high AUCs.
Study details and limits: The article is an abstract-level report from Journal of Pediatric Gastroenterology and Nutrition describing a cross-sectional microbiome analysis in a pediatric cohort. It shows associations between diagnosis and stool microbiome but does not test clinical interventions or prove causation.
Larger and longitudinal studies would be needed to link these microbial differences to outcomes or treatment response.
This is a cross-sectional metagenomic study (abstract-level summary) showing associations, not evidence that altering the microbiome will improve clinical outcomes. Findings need replication and evaluation in longitudinal or interventional studies.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Institutes of Health, award P30 DK078392
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study suggests machine learning of stool microbiome data could eventually help distinguish IBD (especially Crohn’s) from healthy people and some other bowel or systemic conditions.
Postoperative recurrence after ileal resection is common in Crohn’s disease; understanding microbial changes linked to recurrence could help explain mechanisms and guide future biomarker development.
This paper links specific features of the gut bacterial flagellome to TLR5-driven immune activation and reports a disease-associated shift in flagellin profiles in Crohn’s disease and ulcerative colitis, suggesting...
